Orbem and the EIC Accelerator: MRI That Sexes Eggs in a Second
Male chicks of laying breeds never lay eggs, and hatcheries have long killed them on their first day. Germany and France restrict the practice, but in-ovo sexing is not the only possible response: raising male chicks is another. German law contains specified exceptions, while France's published rules include derogations. Austria prohibits killing viable chicks except for feed use; it is not an unconditional ban. Orbem, a Munich spin-off from the Technical University of Munich, does it by putting every egg through a magnetic resonance scanner and letting software read the image.
The European Innovation Council granted €2,450,876 towards an 18-month, €3.51 million project to scale the system. Orbem announced €85.5 million across its Series A and B, including debt in the Series A, opened in the United States and says it is profitable. On its own reported figures, the EIC backed a company that took off. The funding announcements and supplier materials support commercial activity; profitability still requires checking against original accounts.
Company file
- Legal entity
- Orbem GmbH, Munich Local Court HRB 252715
- Founded
- November 2019; Technical University of Munich spin-off
- Managing directors
- Pedro Gómez (co-founder and CEO), Maria Laparidou, Miguel Molina Romero
- Products
- Genus Focus (in-ovo sexing), Genus Scale (fertility detection)
- Markets
- Five European countries; United States since 2025
- Lead investors
- 83North (Series A); Innovation Industries (Series B)
- EIC project
- Orbem Genus, 1 Jun 2022 to 30 Nov 2023, closed
- EIC funding
- Grant only
Where Orbem Stands Today
In January 2026 Orbem announced a €55.5 million Series B led by the Dutch fund Innovation Industries, with Supernova Invest, General Catalyst and its Series A lead 83North; FYB Financial Yearbook reported the same round. The company said it had scanned more than 170 million eggs, operated in five European countries and was "already profitable". It plans to use the money to enter the US market, to apply its scanners to fruit and vegetables, and to develop healthcare uses of what it calls its biological dataset.
The US push is under way. In July 2026 AgFunderNews reported that the first US installation was operating, a second was expected in August and a third was scheduled for 2027. The hatchery was not named. The system processes up to 24,000 eggs an hour, according to the report, and adds about one cent to the retail price of an egg, according to the company representative interviewed. These are company estimates, not independently measured costs or throughput.
The Technology: An MRI Scan for Every Egg
Rival in-ovo sexing methods, as AgFunderNews described them in 2023, either sample fluid from inside the egg (Respeggt, In Ovo) or use hyperspectral imaging that detects feather colour and works in brown-egg breeds (Agri Advanced Technologies). Orbem's system is contactless: an MRI sensor images the egg and an AI model classifies the embryo, which the company says takes less than one second per egg. Orbem separately markets Genus Scale for fertilization detection before incubation; this should not be confused with the embryo-sexing workflow, which typically runs on incubation days 11-12.
"Orbem is the world-first to build patented, end-to-end AI-powered MRI applications."
Orbem Genus project report, CORDISWhat the EIC Project Promised, and What CORDIS Shows
The EIC project
EU contribution: about 70% of a €3.51M project
Orbem Genus ran from June 2022 to November 2023.
CORDIS project 190152213. Values in € millions.
The project aimed to identify fertilisation status, embryo sex and inner egg quality without opening the egg, to cut waste and end the culling of male chicks. The CORDIS report says Orbem scanned "more than 25 Million eggs" during the project, installed its technology in three hatcheries after the legal changes in France and Germany, and saved "more than 10 Million of male chicks from being culled".
The scale
Reported scan totals rose; exact growth is not established
Company-reported cumulative figures, in millions. First two are lower bounds, so their ratio does not establish exact growth. November figure is a product-page total at review.
CORDIS project 190152213 periodic report; Orbem Series B announcement, January 2026.
- Commercial deployment in hatcheriesDeliveredThree hatcheries during the project; five European countries by 2026.
- In-ovo sexing at industrial scaleDelivered25 million eggs by November 2023; 170 million by January 2026, per the company.
- Inner egg quality analyticsPartialFertility detection is a product; a separate inner-egg quality-grading product was not identified in the poultry product pages reviewed on 2 November 2026.
- Independent performance dataNot establishedThe reported 99.5% figure is a company claim. A fully independent validation dataset and protocol were not established from the reviewed company, supplier and CORDIS sources.
What Has Happened Since the Award
The record
From a TU Munich spin-off to US hatcheries
National culling restrictions helped demand alongside voluntary commitments. Commercial milestones and volumes are attributed to company and beneficiary reporting.
- Nov 2019Company foundedOrbem GmbH, Munich, spin-off from the Technical University of Munich
- Jun 2021EIC Accelerator cut-offOrbem Genus submitted: AI-powered MRI to classify eggs without opening them
- Jun 2022EIC project starts18-month project to scale the system in hatcheries€2.45M grant
- Oct 2023Series ADebt and equity round led by 83North€30M
- Nov 2023EIC project closesThree hatcheries, more than 25 million eggs scanned
- 2025US officeFirst US office opened in Houston, Texas
- Jan 2026Series BLed by Innovation Industries; 170 million eggs scanned; company says it is profitable€55.5M
- Jul 2026First US installationFirst system running in a US hatchery; two more planned
- Nov 2026 reviewCompany product-page totals250 million eggs and 11 installations across six countries reported; unaudited totals
German company register via North Data, CORDIS, Orbem, Silicon Canals and AgFunderNews.
The current product page reviewed on 2 November 2026 reports 250 million scanned eggs and 11 installations across six countries. These are company totals without an audit supplied here; the page's counters have changed since the January release. Automation partner Vencomatic also markets Genus Focus, corroborating the product offering, though it is commercially involved rather than an independent performance evaluator.
National laws helped create demand, alongside voluntary industry and retailer commitments. When AgFunderNews reported on the sector in December 2023, citing the nonprofit Innovate Animal Ag, in-ovo sexing covered almost 15% of the EU's laying hens, about 56 million of 389 million, and none in the United States. The European Commission's animal welfare proposal at the time did not include an EU-wide culling ban. The July 2026 company interview describes industry-led adoption in Switzerland and Norway as well as regulatory demand. National bans are therefore one driver, rather than a necessary condition for all European growth.
The Money
The money
EIC grant alongside disclosed Series A and B financing
Selected disclosed funding, not total funding history. Grant is about 2.8% of these three amounts combined; Series A included debt. No causal investment-multiplier inference.
CORDIS; Orbem; Silicon Canals; FYB Financial Yearbook.
Orbem's Series A in October 2023 was a €30 million mix of debt and equity led by 83North, as reported by Silicon Canals and the company. The EIC grant, a grant-only award with no equity, was about 2.8% of the combined grant and disclosed Series A/B amounts shown below; this is a comparison of those selected funding amounts, not a complete funding history.
What cannot be checked
The North Data listing identifies annual reports for 2023 and 2024, but its detailed financial tables require premium access. This review did not retrieve the original filings to check the profitability claim or current revenue. A paywall on this aggregator does not establish that the accounts are unavailable from the German publication system. Egg counts and installation totals above remain attributed to their sources.
Why Europe Should Care
European regulation and animal-welfare commitments helped expand the in-ovo sexing market and a European company says it has scanned more than 170 million eggs in it. Orbem is now exporting that position to the United States, where the practice is not banned, while its investors are betting that the same scanners can be used far beyond eggs.
What the project promised
Contactless, AI-powered MRI classification of eggs to end the culling of male chicks and cut hatchery waste.
What the record shows
Commercial systems in five European countries and one in the US, €85.5M raised and a claimed profit, all reported by the company or its investors.
The Verdict
A market made by regulation
The EIC funded Orbem when national bans were turning in-ovo sexing from an idea into an obligation, and the project ended with the technology in commercial use. Its announced Series A and B together total about 35 times the grant, including debt in the Series A; this is not a measure of grant-caused investment. The success story is credible on the evidence of the funding and installations, while this review has not independently audited its scan totals or reconciled profitability against its filed accounts.
Orbem has not been asked for comment for this article. It is based entirely on public records, company statements and EU project data, linked throughout.
Industry
AgrifoodLivestock
- Focus
- Hatchery technology
- Technologies
- Magnetic resonance imaging
- Artificial intelligence
- Keywords
- In-ovo sexing
- Chick culling
- Animal welfare
- Hatcheries